|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Apr―24 |
P25. Characteristics, treatment options, and predictors of clinical failure among Pseudomonas aeruginosa infection with microbiologically confirmed intermediate or resistant carbapenem susceptibility profile: a multicenter clinical experience on behalf of CASPER (CArbapenem-reSistant Pseudomonas aERuginosa during and after the COVID-19 pandemic) study group |
A Dessilani, S Kaleci, G Orlando, M Del Monte, A Bedini, E Franceschini, et al. (+14) M Albertini, L Benassi, A Oliva, S Mezzadri, M Codeluppi, L Serio, E Biagioni, G Melegari, C Venturelli, M Sarti, L De Pietri, M Girardis, C Mussini, M Meschiari |
2 |
[GO] |
2025―Jan―23 |
P01 Cluster randomized controlled trial (RCT) of Air Filtration to prevent Respiratory Infections (including COVID-19) in care homes: the AFRI-c trial |
Alastair Hay, Rachel Brierley, Nick Turner, Joanna Thorn, Sophie Rees, Jodi Taylor, et al. (+11) Tomas Welsh, Emily Henderson, Jane Sprackman, Gemma Morgan, Craig Riddington, Laurel Campbell-Smith, Claire Brown, Derren Ready, Graziella Mazza, Eleanor Gidman, Ruth Kipping |
3 |
[GO] |
2024―Aug―23 |
O04 UKHSA Start Smart Then Focus antimicrobial stewardship: effective implementation during the COVID-19 pandemic at an NHS Foundation Trust in the UK |
Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour |
4 |
[GO] |
2024―Aug―23 |
P11 Pharmacists’ knowledge, attitudes and perceptions towards antimicrobial stewardship and resistance during the COVID-19 pandemic at secondary care settings in the UK |
Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour |
5 |
[GO] |
2024―Jun―11 |
Antibiotic prescribing and bacterial infection in COVID-19 inpatients in Southeast Asia: a systematic review and meta-analysis |
Achiraya Chanapal, Hung-Yung Cheng, Helen Lambert, Wenjuan Cong |
6 |
[GO] |
2024―Mai―27 |
Antibiotic utilization patterns in Tanzania: a retrospective longitudinal study comparing pre- and intra-COVID-19 pandemic era using Tanzania Medicines and Medical Devices Authority data |
Raphael Z Sangeda, Sahani M William, Faustine C Masatu, Adonis Bitegeko, Yonah H Mwalwisi, Emmanuel A Nkiligi, et al. (+2) Pius G Horumpende, Adam M Fimbo |
7 |
[GO] |
2024―Apr―24 |
Comparing indicators of disease severity among patients presenting to hospital for urinary tract infections before and during the COVID-19 pandemic |
Selina Patel, Martin Gill, Andrew Hayward, Susan Hopkins, Andrew Copas, Laura Shallcross |
8 |
[GO] |
2024―Feb―22 |
Hospital prescribing patterns of antibiotics in Zambia using the WHO prescribing indicators post-COVID-19 pandemic: findings and implications |
Steward Mudenda, Robert Chilimboyi, Scott Kaba Matafwali, Victor Daka, Ruth Lindizyani Mfune, Loriane Arielle Mobou Kemgne, et al. (+5) Flavien Nsoni Bumbangi, Jimmy Hangoma, Billy Chabalenge, Larry Mweetwa, Brian Godman |
9 |
[GO] |
2024―Feb―07 |
Should we stop referring to the pandemic of antimicrobial resistance as silent? |
Miroslav Sirota |
10 |
[GO] |
2024―Feb―07 |
Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis |
Sidra Khan, Stuart E Bond, Jade Lee-Milner, Barbara R Conway, William J Lattyak, Mamoon A Aldeyab |
11 |
[GO] |
2023―Nov―13 |
Antimicrobial prescribing in a secondary care setting during the COVID-19 pandemic |
Michael M Tadros, Marian S Boshra, Michael Scott, Glenda Fleming, Fidelma Magee, Mohammad I Hamed, et al. (+4) Ahmed Abuelhana, Aaron Courtenay, Heba F Salem, Kathryn Burnett |
12 |
[GO] |
2023―Aug―02 |
P16 COVID-19 and urinary tract infection: the main manifestations and their management |
Kiarina Chichirelo-Konstantynovych, Tetyana Konstantynovych |
13 |
[GO] |
2023―Aug―02 |
P15 Women’s satisfaction with the management of urinary tract infections during the COVID-19 pandemic: a qualitative analysis of free-text comments from a national survey in England |
A’mar Dababneh, Leigh Sanyaolu, Haroon Ahmed, Dushyanthi Alagiyawanna, Donna Lecky, Emily Cooper |
14 |
[GO] |
2023―Jul―17 |
The impact of COVID-19 national restrictions on dental antibiotic dispensing trends and treatment activity in England: January 2016 to July 2021 |
Angela Falola, Alicia Demirjian, Wendy Thompson, Colin S Brown, Sarah Gerver, Sabine Bou-Antoun |
15 |
[GO] |
2023―Jun―14 |
P17 Aetiology of hospital-acquired Gram-negative bacteraemias over the COVID-19 pandemic: a single NHS Trust experience, UK |
Syra Dhillon, Oscar Buchanan, Catherine Sargent |
16 |
[GO] |
2023―Jun―09 |
Knowledge, attitude and practice of healthcare workers towards antibiotic resistance during the COVID-19 pandemic |
Hadi Al Sulayyim, Rohani Ismail, Abdullah Al Hamid, Noraini Abdul Ghafar |
17 |
[GO] |
2023―Feb―11 |
Sustained increases in antibiotic prescriptions per primary care consultation for upper respiratory tract infections in England during the COVID-19 pandemic |
Zheyuan Yang, Sabine Bou-Antoun, Sarah Gerver, Thomas E Cowling, Rachel Freeman |
18 |
[GO] |
2023―Jan―19 |
P16 Overuse of antibiotics during the first year of the COVID-19 pandemic in Poland |
Izabella Owsianka, Mateusz Gajda, Paweł Krzyściak, Barbara Gryglewska, Anna Różańska, Jadwiga Wójkowska-Mach |
19 |
[GO] |
2022―Dez―13 |
A cross-sectional study of hospital antimicrobial stewardship programmes in the COVID-19 era |
Valerie Leung, Jacquelyn Quirk, Sarah Muir, Nick Daneman, Kevin L Schwartz, Bradley J Langford |
20 |
[GO] |
2022―Dez―07 |
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review |
Lucy S Witt, Jessica R Howard-Anderson, Jesse T Jacob, Lindsey B Gottlieb |
21 |
[GO] |
2022―Jun―16 |
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) |
Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Valentina Galfo, Sara Occhineri, Stefano Verdenelli, et al. (+23) Giancarlo Ceccarelli, Melita Poli, Marco Merli, Davide Bavaro, Anna Carretta, Giuseppe Nunnari, Emmanuele Venanzi Rullo, Enrico Maria Trecarichi, Chiara Papalini, Antonina Franco, Rosa Fontana Del Vecchio, Vincenzo Bianco, Rodolfo Punzi, Daniela Francisci, Raffaella Rubino, Carlo Torti, Massimo Puoti, Sergio Carbonara, Antonio Cascio, Annalisa Saracino, Teresa Santantonio, Mario Venditti, Francesco Menichetti |
22 |
[GO] |
2022―Jun―01 |
P12 Antibiotic prescribing in hospitalized patients with COVID-19 as a function of inflammatory markers in Wave 1 versus Wave 2: a systematic review |
Saif Abbas Chatoo, Emma Thomas-Jones, Philip Pallmann, Joanne Euden |
23 |
[GO] |
2022―Jun―01 |
P05 The impact of COVID-19 on antifungal stewardship in a UK tertiary teaching hospital: a review of prescribing practices and therapeutic drug monitoring of posaconazole |
Adam Andreani, Netta Tyler, Christiane Micallef, David Enoch, Vanessa Wong |
24 |
[GO] |
2022―Mrz―16 |
Antibiotic resistance: calling time on the ‘silent pandemic’ |
Marc Mendelson, Michael Sharland, Mirfin Mpundu |
25 |
[GO] |
2022―Feb―16 |
P36 Procalcitonin as an antimicrobial stewardship tool in the COVID-19 era: a single centre experience |
Margaret Creedon, Alida Fe Talento, Roisin Connolly, Aine Egan, Tidi Hassan, Marta Trzos-Grzybowksa |
26 |
[GO] |
2022―Feb―16 |
P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study |
Joanne Euden, Philip Howard, Neil Powell, Martin J. Llewelyn, Tamas Szakmany, Mahableswhar Albur, et al. (+17) Stuart E. Bond, Lucy Brookes-Howell, Paul Dark, Thomas P. Hellyer, Susan Hopkins, Iain J. McCullagh, Margaret Ogden, Philip Pallmann, Helena Parsons, David G. Partridge, Dominick E. Shaw, Bethany Shinkins, Stacy Todd, Emma Thomas-Jones, Robert West, Enitan D. Carrol, Jonathan A. T. Sandoe |
27 |
[GO] |
2022―Feb―16 |
O03 The impact of COVID-19 infection prevention and control measures on transmission of hospital-acquired infections and antimicrobial resistance in Africa |
Linzy Elton, Muzamil M. Abdel Hamid, John Tembo, Hana Elbadawi, Kwitaka Maluzi, Mohamed H. Abdelraheem, et al. (+5) Timothy D. McHugh, Isobella Honeyborne, Kerry Roulston, Margaret J. Thomason, Alimuddin Zumla |
28 |
[GO] |
2022―Feb―16 |
P12 Important early prognostic laboratory indicators for COVID-19 mortality |
Ergys Ramosaço, Entela Kolovani, Nevila Gjermeni, Najada Çomo |
29 |
[GO] |
2022―Feb―16 |
P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship |
Lois Hawkins, Ting Yau, Tihana Bicanic, Marina Basarab |
30 |
[GO] |
2022―Feb―16 |
P27 Bacterial coinfection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis |
Maria Calderon, Grace Gysin, Sarah Walpole, Felicity Mills, Daniel Comandé, Ewan Hunter |
31 |
[GO] |
2022―Feb―16 |
P30 Bacterial coinfection and prescribing trends in SARS-CoV-2 infection in two UK hospitals |
P. J. Teoh, I. Maan, J. Uwagwu, A. Odedra |
32 |
[GO] |
2021―Sep―07 |
Educational Resource Review: MSD’s The Steward-Episode 6-The impact of COVID-19 on AMS |
|
33 |
[GO] |
2021―Aug―28 |
Erratum to: Education: The role of the first siderophore cephalosporin Fetcroja® (cefiderocol) in UK clinical practice: introduction; Antibiotic resistance during and beyond COVID-19; Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice; Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa; Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection; Education: An overview from the author of ‘Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients’ |
|
34 |
[GO] |
2020―Dez―09 |
Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection |
Liam Townsend, Gerry Hughes, Colm Kerr, Mary Kelly, Roisin O’Connor, Eileen Sweeney, et al. (+5) Catriona Doyle, Ruth O’Riordan, Ignacio Martin-Loeches, Colm Bergin, Ciaran Bannan |
35 |
[GO] |
2020―Apr―08 |
Infection prevention and control (IPC) for novel coronavirus (COVID-19) |
|